Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Watz

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Pneumologie (Stuttgart, Germany)|September 10, 2019
[Expert Workshop COPD: Lungs and Heart - Quite Often Ill Together]B Jany, R Bals, M Dreher, et al.
Pneumologie (Stuttgart, Germany)|November 19, 2020
[Group Training of Patients with Chronic Lung Diseases under Outpatient Conditions - Recommendations of the Working Group Lung Sports in Germany and the German Airways League]H Worth, R Bock, M Frisch, et al.
Pneumologie (Stuttgart, Germany)|November 9, 2020
[Group Training of Patients with Chronic Lung Diseases under Outpatient Conditions - Recommendations of the Working Group Lung Sports in Germany and the German Airways League]H Worth, R Bock, M Frisch, et al.
Pneumologie (Stuttgart, Germany)|June 10, 2010
[COPD and infection]R Bals, A Gillissen, J Lorenz, et al.
Pulmonary Pharmacology & Therapeutics|August 22, 2017
Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPDA Cahn, J N Hamblin, M Begg, et al.
Respiratory Medicine|June 17, 2019
Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the COSYCONET cohortF C Trudzinski, K Kahnert, C F Vogelmeier, et al.
Pneumologie (Stuttgart, Germany)|March 10, 2018
[Guideline for the Diagnosis and Treatment of COPD Patients - Issued by the German Respiratory Society and the German Atemwegsliga in Cooperation with the Austrian Society of Pneumology]C Vogelmeier, R Buhl, O Burghuber, et al.
Respiratory Research|January 22, 2020
The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONETK Kahnert, M Föhrenbach, T Lucke, et al.
Scientific Reports|July 1, 2020
Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONETF C Trudzinski, R A Jörres, P Alter, et al.
Respiratory Research|January 24, 2024
Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD-results from COSYCONETS Fähndrich, C Herr, S Teuteberg, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Pneumologie (Stuttgart, Germany)|September 10, 2019
[Expert Workshop COPD: Lungs and Heart - Quite Often Ill Together]B Jany, R Bals, M Dreher, et al.
Pneumologie (Stuttgart, Germany)|November 19, 2020
[Group Training of Patients with Chronic Lung Diseases under Outpatient Conditions - Recommendations of the Working Group Lung Sports in Germany and the German Airways League]H Worth, R Bock, M Frisch, et al.
Pneumologie (Stuttgart, Germany)|November 9, 2020
[Group Training of Patients with Chronic Lung Diseases under Outpatient Conditions - Recommendations of the Working Group Lung Sports in Germany and the German Airways League]H Worth, R Bock, M Frisch, et al.
Pneumologie (Stuttgart, Germany)|June 10, 2010
[COPD and infection]R Bals, A Gillissen, J Lorenz, et al.
Pulmonary Pharmacology & Therapeutics|August 22, 2017
Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPDA Cahn, J N Hamblin, M Begg, et al.
Respiratory Medicine|June 17, 2019
Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the COSYCONET cohortF C Trudzinski, K Kahnert, C F Vogelmeier, et al.
Pneumologie (Stuttgart, Germany)|March 10, 2018
[Guideline for the Diagnosis and Treatment of COPD Patients - Issued by the German Respiratory Society and the German Atemwegsliga in Cooperation with the Austrian Society of Pneumology]C Vogelmeier, R Buhl, O Burghuber, et al.
Respiratory Research|January 22, 2020
The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONETK Kahnert, M Föhrenbach, T Lucke, et al.
Scientific Reports|July 1, 2020
Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONETF C Trudzinski, R A Jörres, P Alter, et al.
Respiratory Research|January 24, 2024
Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD-results from COSYCONETS Fähndrich, C Herr, S Teuteberg, et al.
Pageof 4